Follow the 알지노믹스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 알지노믹스 has published 20 insider filings. Market capitalisation: €753.3bn. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 이성욱. All data is openly available.
20
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
4 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Algenomics is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.